Partners Group appoints Pete Zippelius as new Co-Head of Private Equity Health & Life 01.04.2026, 09:00 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Partners Group Holding 904,60 EUR -1,88 % Lang & Schwarz

Partners Group / Key word(s): Personnel
Partners Group appoints Pete Zippelius as new Co-Head of Private Equity Health & Life

01.04.2026 / 09:00 CET/CEST


Baar-Zug, Switzerland; 1 April 2026

  • The role will be based at Partners Group's US headquarters
  • Pete will be responsible for new investments and value creation initiatives across the firm’s Health & Life portfolio
  • Partners Group has a strong track record in Health & Life, with approximately USD 13.2 billion invested in the sector to-date

Partners Group, one of the largest firms in the global private markets industry, has appointed Pete Zippelius as Co-Head of its Private Equity Health & Life Vertical. Pete will be based at Partners Group’s US headquarters and will join the firm in September 2026.

Pete will co-lead the Private Equity Health & Life Vertical alongside Benjamin Breier, who joined the firm in 2022. In this role, he will be responsible for originating, underwriting, and executing new investments, as well as overseeing transformational value creation initiatives across the firm’s Health & Life portfolio. The Private Equity Health & Life Vertical comprises around 40 investment professionals across Europe, the US, and Asia-Pacific and forms part of Partners Group’s global Private Equity business.

Before joining Partners Group, Pete spent over two decades in private equity and investment banking roles. Most recently, he was Investment Partner and member of the Investment Committee and Operating Committee at Leonard Green & Partners where he led and managed USD 8 billion of equity investments in the healthcare and life sciences industry across large-cap, middle-market, structured equity, debt, and secondaries strategies. In addition, Pete played a central role in designing and building Leonard Green's operating structure including industry verticals, professional development, cross fund staffing, CRM implementation, and leadership committees, and also supported the firm’s expansion into additional fund strategies.

Earlier in his career, Pete held senior leadership positions in healthcare investment banking, including Co-Head of North American Healthcare Investment Banking at J.P. Morgan, Co-Head of Healthcare Services Investment Banking at Deutsche Bank, and Managing Director at Morgan Stanley, where he advised on and executed a broad range of healthcare services, life sciences, and healthcare technology transactions globally.

Wolf Scheider, Head of Private Equity, Partners Group, comments: "Pete brings deep sector expertise and a proven track record of building and scaling high-quality healthcare and life sciences businesses. Our thematic research continues to identify compelling opportunities driven by demographic trends, innovation, and healthcare system transformation, and Pete will play a key role in further strengthening our Health & Life platform globally."

Pete Zippelius adds: "Partners Group is one of the best positioned private markets firms in the world. Furthermore, their integrated private markets platform and long-term, thematic investment approach are highly differentiated. I am excited to join the firm and work with the team to identify new investment opportunities and to help build leading healthcare and life businesses across the portfolio."

Benjamin Breier, Co-Head Private Equity Health & Life, Partners Group, concludes: "Pete is a highly respected investor that I have known and worked with for over two decades. The healthcare and life sciences sectors continue to offer compelling investment opportunities and Peter’s capabilities across origination, investment, and value creation will be valuable as we look to capitalize on this. We are excited to welcome Pete to the Partners Group Health & Life team."

Partners Group has an established presence in the Health & Life sector, with investments spanning healthcare services, life sciences, medical technology, and related subsectors, and has generated significant value for its clients through active ownership and operational value creation.

This appointment follows the recent appointments of Nicholas Smith Wang as Co-Head of Private Equity Technology and Tarak Mehta as Co-head of Private Equity Goods & Products, underlining Partners Group’s continued commitment to strengthening its private equity leadership team. Partners Group’s Private Equity business has USD 86 billion in overall assets under management globally.

About Partners Group
Partners Group is one of the largest firms in the global private markets industry, with around 2’000 professionals and over USD 185 billion in assets under management globally. The firm has investment programs and custom mandates spanning private equity, private credit, infrastructure, real estate, royalties, and special opportunities. With its heritage in Switzerland and primary presence in the Americas in Colorado, Partners Group is built differently from the rest of the industry. The firm leverages its differentiated culture and its operationally oriented approach to identify attractive investment themes and to transform businesses and assets into market leaders. For more information, please visit www.partnersgroup.com or follow us on LinkedIn.

Media relations contact
Henry Weston
Phone: +44 207 575 2593
Email: henry.weston@partnersgroup.com



End of Media Release
View original content: EQS News


Language: English
Company: Partners Group
Zugerstrasse 57
6341 Baar
Switzerland
Phone: +41 41 784 60 00
Fax: + 41 41 784 60 01
E-mail: partnersgroup@partnersgroup.com
Internet: https://www.partnersgroup.com/en/
ISIN: CH0024608827
Valor: 2460882
Listed: SIX Swiss Exchange
EQS News ID: 2301968

 
End of News EQS News Service

2301968  01.04.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Werbung
Weiter abwärts?
Kurzfristig positionieren
Ask: 1,52
Hebel: 6
mit moderatem Hebel
Smartbroker
Goldman Sachs
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: GW1DDW. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
News-Kommentare
Thema
1 Trump: USA erwägen Truppenreduzierung in Deutschland Hauptdiskussion
2 Ölpreis zieht an - Trump droht dem Iran erneut Hauptdiskussion
3 Zahl der Geburten in Deutschland auf niedrigstem Stand der Nachkriegszeit Hauptdiskussion
4 KI-Nutzung in Deutschland nimmt rasant zu Hauptdiskussion
5 Klingbeil plant härtere Gangart gegen Steuerbetrüger Hauptdiskussion
Alle Diskussionen
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer